These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29454627)

  • 1. Changes in salsolinol production and salsolinol synthase activity in Parkinson's disease model.
    Zheng X; Chen X; Guo M; Ali S; Huang Y; Sun F; Liu K; Chen Z; Deng Y; Zhong R
    Neurosci Lett; 2018 Apr; 673():39-43. PubMed ID: 29454627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and Sequencing of Salsolinol Synthase, an Enzyme Catalyzing Salsolinol Biosynthesis.
    Chen X; Zheng X; Ali S; Guo M; Zhong R; Chen Z; Zhang Y; Qing H; Deng Y
    ACS Chem Neurosci; 2018 Jun; 9(6):1388-1398. PubMed ID: 29602279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sal synthase induced cytotoxicity of PC12 cells through production of the dopamine metabolites salsolinol and N-methyl-salsolinol.
    Xiong Q; Zheng X; Wang J; Chen Z; Deng Y; Zhong R; Wang J; Chen X
    J Integr Neurosci; 2022 Mar; 21(2):71. PubMed ID: 35364659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease.
    Naoi M; Maruyama W; Dostert P; Hashizume Y
    J Neural Transm Suppl; 1997; 50():89-105. PubMed ID: 9120428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
    Naoi M; Maruyama W; Nagy GM
    Neurotoxicology; 2004 Jan; 25(1-2):193-204. PubMed ID: 14697894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mechanism of Action of Salsolinol in Brain: Implications in Parkinson's Disease.
    Voon SM; Ng KY; Chye SM; Ling APK; Voon KGL; Yap YJ; Koh RY
    CNS Neurol Disord Drug Targets; 2020; 19(10):725-740. PubMed ID: 32881676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salsolinol, a dopamine-derived tetrahydroisoquinoline, induces cell death by causing oxidative stress in dopaminergic SH-SY5Y cells, and the said effect is attenuated by metallothionein.
    Wanpen S; Govitrapong P; Shavali S; Sangchot P; Ebadi M
    Brain Res; 2004 Apr; 1005(1-2):67-76. PubMed ID: 15044066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of idiopathic Parkinson's disease].
    Maruyama W
    Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):494-7. PubMed ID: 11523160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell death in Parkinson's disease.
    Maruyama W; Naoi M
    J Neurol; 2002 Sep; 249 Suppl 2():II6-10. PubMed ID: 12375057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of (R)-salsolinol and N-methyl-(R)-salsolinol on the balance impairment between dopamine and acetylcholine in rat brain: involvement in pathogenesis of Parkinson disease.
    Zhu W; Wang D; Zheng J; An Y; Wang Q; Zhang W; Jin L; Gao H; Lin L
    Clin Chem; 2008 Apr; 54(4):705-12. PubMed ID: 18238832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.
    Naoi M; Maruyama W; Akao Y; Yi H
    Neurotoxicol Teratol; 2002; 24(5):579-91. PubMed ID: 12200189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (R)salsolinol N-methyltransferase activity increases in parkinsonian lymphocytes.
    Naoi M; Maruyama W; Nakao N; Ibi T; Sahashi K; Benedetti MS
    Ann Neurol; 1998 Feb; 43(2):212-6. PubMed ID: 9485062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell death of dopamine neurons in aging and Parkinson's disease.
    Naoi M; Maruyama W
    Mech Ageing Dev; 1999 Nov; 111(2-3):175-88. PubMed ID: 10656535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased vulnerability of parkin knock down PC12 cells to hydrogen peroxide toxicity: the role of salsolinol and NM-salsolinol.
    Su Y; Duan J; Ying Z; Hou Y; Zhang Y; Wang R; Deng Y
    Neuroscience; 2013 Mar; 233():72-85. PubMed ID: 23291452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells.
    Wang R; Qing H; Liu XQ; Zheng XL; Deng YL
    Neurosci Bull; 2008 Jun; 24(3):125-32. PubMed ID: 18500384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic polysystemic candidiasis as a possible contributor to onset of idiopathic Parkinson's disease.
    Epp LM; Mravec B
    Bratisl Lek Listy; 2006; 107(6-7):227-30. PubMed ID: 17051898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study.
    Maruyama W; Nakahara D; Ota M; Takahashi T; Takahashi A; Nagatsu T; Naoi M
    J Neurochem; 1992 Aug; 59(2):395-400. PubMed ID: 1629715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons.
    Naoi M; Maruyama W; Akao Y; Zhang J; Parvez H
    Toxicology; 2000 Nov; 153(1-3):123-41. PubMed ID: 11090952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic salsolinol administration prevents the behavioral and neurochemical effects of L-DOPA in rats.
    Wąsik A; Romańska I; Michaluk J; Antkiewicz-Michaluk L
    Neurotox Res; 2015 May; 27(4):399-410. PubMed ID: 25711629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salsolinol, an endogenous compound triggers a two-phase opposing action in the central nervous system.
    Możdżeń E; Kajta M; Wąsik A; Lenda T; Antkiewicz-Michaluk L
    Neurotox Res; 2015 Apr; 27(3):300-13. PubMed ID: 25537852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.